Physiologically‐Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective (original) (raw)
Simulation-Based Analysis of the Impact of Renal Impairment on the Pharmacokinetics of Highly Metabolized Compounds
Marilyn Morris
Pharmaceutics, 2019
View PDFchevron_right
The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvement
Jan Snoeys
Expert Opinion on Drug Metabolism & Toxicology, 2014
View PDFchevron_right
Utilization of Physiologically Based Pharmacokinetic Modeling in Clinical Pharmacology and Therapeutics: an Overview
Grace Davis
Current Pharmacology Reports
View PDFchevron_right
Commentary on “physiologically based pharmacokinetic modeling as a tool for drug development”
Thomas Ludden
Journal of Pharmacokinetics and Biopharmaceutics, 1995
View PDFchevron_right
Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs
Marjoleen Nijsen
Drug metabolism and disposition: the biological fate of chemicals, 2007
View PDFchevron_right
A Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics
Neil Parrott
Clinical Pharmacokinetics, 2006
View PDFchevron_right
Physiological-based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20-years; in- depth analysis of applications, organizations, and platforms
Amais Ahmad, Amin Rostami-hodjegan, Susan Murby, Susan Burkhill, Eman El-Khateeb
Bipharmaceutics and Drug Disposition, 2020
View PDFchevron_right
Physiologically based and population PK modeling in optimizing drug development: A predict-learn-confirm analysis
Ajit Suri
Clinical pharmacology and therapeutics, 2015
View PDFchevron_right
Requirements to Establishing Confidence in Physiologically Based Pharmacokinetic (PBPK) Models and Overcoming Some of the Challenges to Meeting Them
Hugues Dolgos
Clinical Pharmacokinetics
View PDFchevron_right
Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review
Eva Noor
Clinical Pharmacology & Therapeutics, 2011
View PDFchevron_right
An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery
Neil Parrott
Journal of Pharmaceutical Sciences, 2005
View PDFchevron_right
Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases
Ramsha Khalid
Scientific Reports
View PDFchevron_right
Comparative assessment of In Vitro-In Vivo extrapolation methods used for predicting hepatic metabolic clearance of drugs
Sami Haddad
Journal of Pharmaceutical Sciences, 2012
View PDFchevron_right
Physiologically based pharmacokinetic (PBPK) modelling tools: How to fit with our needs?
francois bouzom
Biopharmaceutics & Drug Disposition
View PDFchevron_right
Physiologically-Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective
Aleksandrs Odinecs
Clinical pharmacology and therapeutics, 2018
View PDFchevron_right
Current PBPK Models: Are They Predicting Tissue Drug Concentration Correctly?
Pietro Fagiolino
Drugs in R&D
View PDFchevron_right
Application of Full Physiological Models for Pharmaceutical Drug Candidate Selection and Extrapolation of Pharmacokinetics to Man
Neil Parrott
Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology, 2005
View PDFchevron_right
A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation
Hari Kangne
Scientific Reports, 2019
View PDFchevron_right
In vitro-in vivo extrapolation of clearance: Modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods
Sami Haddad
Journal of Pharmaceutical Sciences, 2012
View PDFchevron_right
The Perks and Drawbacks of Physiologically-Based Pharmacokinetic Modeling
Alejandra Mateos
Medical Research Archives
View PDFchevron_right
Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability
Charles Stankovic
International journal of pharmaceutics, 2006
View PDFchevron_right
Application of drug metabolism and pharmacokinetics for new drug development
Yoon Gyoon Kim
Archives of Pharmacal Research, 2011
View PDFchevron_right
Quantitative structure-pharmacokinetic relationships for the prediction of renal clearance in humans
Marilyn Morris
Drug metabolism and disposition: the biological fate of chemicals, 2015
View PDFchevron_right
Applications of Pharmacokinetic Principles in Drug Development
Roger Jelliffe, Michael Van Guilder
2004
View PDFchevron_right
Physiologically Based Pharmacokinetics: A Simple, All Purpose Model
Gaetano Lamberti
Industrial & Engineering Chemistry Research, 2010
View PDFchevron_right
Erratum: Physiology-based pharmacokinetic modeling: Ready to be used (Drug Discovery Today: Technologies 10.1016/j.ddtec.2004.09.006)
Walter Schmitt
2005
View PDFchevron_right
Prediction of the Effects of Renal Impairment on Clearance for Organic Cation Drugs that Undergo Renal Secretion: A Simulation-Based Study
Marilyn Morris
Drug Metabolism and Disposition, 2018
View PDFchevron_right
Deciding on success criteria for predictability of pharmacokinetic parameters from in vitro studies: an analysis based on in vivo observations
Khaled Abduljalil
Drug metabolism and disposition: the biological fate of chemicals, 2014
View PDFchevron_right
A Strategy to Refine the Phenotyping Approach and Its Implementation to Predict Drug Clearance: A Physiologically Based Pharmacokinetic Simulation Study
Andrew McLachlan
CPT: Pharmacometrics & Systems Pharmacology
View PDFchevron_right
Utilizing Physiologically Based Pharmacokinetic Modeling to Inform Formulation and Clinical Development for a Compound with pH-Dependent Solubility
Anne Paccaly
Journal of Pharmaceutical Sciences, 2015
View PDFchevron_right
The pivotal role of drug metabolism and pharmacokinetics in the discovery and development of new medicines
Alan Palmer
IDrugs, 2004
View PDFchevron_right